HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,469-6,480 of 27,277
Drug study icon
CompletedEUCTR 2018-002782-19

A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS AN ADJUNCT TO ANTIDEPRESSANTS IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE HAD AN INADEQUATE RESPONSE TO ANTIDEPRE...

This study has finished and is no longer accepting participants.

Recruitment status comes from the linked ClinicalTrials.gov record. Both registries list the identifiers for the same study.

Multiple locations, including Phoenix
DepressionHistorical research recordAges 18–65
Countries
United States, United Kingdom, Bulgaria, + 4 others
Sponsor
Allergan Ltd.
Drug study icon
CompletedEUCTR 2014-004393-41

A double-blind, placebo-controlled study of the impact of prophylactic treatment with Galantamine 8mg of cognitive impairment during an electroconvulsive therapy (ECT) in patients with major depre...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium
Sponsor
CUB Hospital Erasme
Drug study icon
CompletedNCT00518323

Safety and Efficacy of Paliperidone Extended Release (ER) for schizophrenia

What is this study about?

Researchers compared Paliperidone ER and placebo to find out how the approaches affected psychotic symptoms in young people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
SchizophreniaMedication studyAges 12–17
Countries
United States, India, Romania, + 2 others
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedEUCTR 2010-018671-20

A Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolarity type 1 (Phas...

Official study title

A Double-Blind, Placebo-Controlled Trial of Asenapine in the Prevention of Recurrence of a Mood Episode After Stabilization of an Acute Manic/Mixed Episode in Subjects With Bipolar 1 Disorder (Phas...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
BipolarityHistorical research record
Countries
Bulgaria
Sponsor
Forest Research Institute Inc., a wholly owned subsidiary of Forest Laboratories, LLC
Drug study icon
CompletedEUCTR 2011-005138-21

A double-blind, placebo-controlled, multicenter, parallel group study to assess efficacy, safety and tolerability of TC-5619 as augmentation therapy to improve negative symptoms and cognition in ou...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Hungary
SchizophreniaHistorical research record
Countries
Hungary
Sponsor
Targacept Inc.
Drug study icon
CompletedEUCTR 2009-016667-11

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/day) as Adjunctive Therapy in Adults With Major D...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Bipolarity, DepressionHistorical research record
Countries
France, Bulgaria, Spain
Sponsor
Cephalon, Inc.
Drug study icon
CompletedEUCTR 2010-023623-26

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as Adjunctive Therapy in Adults With Major Depressio...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Bipolarity, DepressionHistorical research record
Countries
Bulgaria, Finland, Germany, + 3 others
Sponsor
Cephalon, Inc.
Drug study icon
CompletedEUCTR 2006-003739-57

A double-blind, randomised, parallel-group, placebo-controlled study investigating the safety- and tolerability following fixed oral dose regimens (daily versus twice weekly administration) of Lu 3...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
SchizophreniaHistorical research record
Countries
Germany, Slovakia
Sponsor
H. Lundbeck A/S

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.